Status:
COMPLETED
Bilateral Sphenopalatine Ganglion Block With or Without Bilateral Greater Occipital Nerve Block for Treatment of Obstetric Post-Dural Puncture Headache
Lead Sponsor:
Zagazig University
Conditions:
Post-Dural Puncture Headache
Eligibility:
FEMALE
21-40 years
Phase:
NA
Brief Summary
Post-dural puncture headache is a common complication, following neuraxial techniques. The obstetric population is particularly prone to PDPH. Therefore, treatment of PDPH is a key issue in obstetric ...
Detailed Description
Post-dural puncture headache (PDPH) is a relatively common complication following dural puncture which is more frequently noted in parturients undergoing cesarean section (CS) under neuraxial anesthes...
Eligibility Criteria
Inclusion
- Patient acceptance.
- Age 21- 40 years old.
- Post-partum females suffering PDPH with visual analogue score (VAS) ≥ 4 and modified Lybecker classification score ≥ 2
- ASA II (due to pregnancy).
- Body mass index \< 35Kg/m2
- Accepted mental state of the patient.
Exclusion
- Emergent cesarean section.
- Hypertensive disorders of the pregnancy.
- History of allergy to local anesthetics.
- History of chronic headache, migraine, convulsions, and cerebrovascular accident.
- Contraindication to spinal anesthesia: coagulopathy, infection at site of injection.
- Inadequate temporal window
Key Trial Info
Start Date :
June 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04844229
Start Date
June 20 2021
End Date
June 30 2022
Last Update
October 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig University
Zagazig, Sharqia Province, Egypt